Dnmt3a, a regulatory factor originally identified in DNA methylase, has been shown to play a role in a variety of diseases, including inflammation, immunity and tumor (Abplanalp et al., 2021; Brunetti, Gundry & Goodell, 2017). This evidence concerns the gene DNMT3A and neoplasm.